前收市價 | 35.54 |
開市 | 34.51 |
買盤 | 33.25 x 100 |
賣出價 | 33.91 x 100 |
今日波幅 | 32.03 - 35.09 |
52 週波幅 | 3.03 - 49.87 |
成交量 | |
平均成交量 | 457,945 |
市值 | 351.991M |
Beta 值 (5 年,每月) | 2.47 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -10.31 |
業績公佈日 | 2024年5月07日 - 2024年5月13日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 55.00 |
Small-cap stocks tend to outperform their larger brethren over time. After several years of underperformance, it looked like the little guys were going to start winning again. Inflation was moderating and the Federal Reserve was hinting it would cut interest rates at least three times this year. Beginning last October, the performance of the Russell 2000 index of small-cap stocks started pulling away from that of the S&P 500. But it wouldn’t last. Runaway government spending drove inflation high
The best biotech stocks to buy are in companies that put a lot of resources into research and development, often with nothing to show for it for years. Regulatory hurdles make finding biotech stocks to buy challenging if you don’t have the patience to wait it out. But when biotech companies win approval to sell and marketing a drug, the potential for profits can be off the charts. That’s why it’s a good idea to at least consider biotech, and whether they have a spot in your portfolio.InvestorPla
This article will discuss the 26 biggest marijuana companies in the world, understand some recent industry trends, and navigate the future of the marijuana industry. If you want to skip our detailed analysis, you can head directly to the 5 Biggest Marijuana Companies in the World. An Analysis of the Cannabis Industry According to a […]